#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Germ cell cancer Epstein-Barr virus infection Necrotising myositis Acromegaly Loss of consciousness Usher's syndrome Pulmonary fibrosis Chondrosarcoma Glomerulonephritis chronic Immune-mediated enterocolitis Prostate cancer Iron overload Progressive supranuclear palsy Mucopolysaccharidosis I Encephalitis autoimmune More trials…

    Learn about Rare Diseases

    Lysosomal storage disorder – Basic Information Leukoencephalopathy – Life with Disease Medulloblastoma – Basic Information Choroid melanoma – Trials in Disease Primary mediastinal large B-cell lymphoma Alveolar rhabdomyosarcoma – Diagnostics Nephroblastoma – Diagnostics Factor IX deficiency – Treatment Undifferentiated sarcoma – Basic Information Antisynthetase syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sirexatamab Hydroxypropyl Cellulose Lf Atrasentan Hydrochloride Aavanc80-3'Hotof Mps-102 Vgl101 Mycophenolate Mofetil Golexanolone Doxycycline ATIGOTATUG Lasmiditan APROTININ Betamethasone Dipropionate Highly Refined Fish Oil Zenocutuzumab Omeprazole Fluoroestradiol F-18 Sodium Hydrogen Carbonate SECRETIN SYNTHETIC HUMAN Livmoniplimab More therapies…

    Learn about Your Condition

    Familial hypertriglyceridaemia Angelman's syndrome Diabetes mellitus Urticaria chronic Procedural haemorrhage Optic atrophy Neurofibrosarcoma Wolfram syndrome Cervix carcinoma stage III Endotracheal intubation Venous thrombosis Fibrosarcoma metastatic Rubella Cerebral haemorrhage Thyroidectomy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on the Effects of Calcium Folinate in Patients with Kearns-Sayre Syndrome and Cerebral Folate Deficiency

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Kearns-Sayre syndrome
    Investigated Drugs:
    • ANHYDROUS CALCIUM FOLINATE
    Germany

  • Study on Contact X-ray Brachytherapy with Capecitabine for Rectal Cancer Preservation in Adults with Intermediate Stage Rectal Adenocarcinoma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Rectal adenocarcinoma
    Investigated Drugs:
    • Capecitabine
    • Fluorouracil
    • Folinic Acid
    France

  • Study Comparing Corifollitropin Alfa and Progestin Primed Ovarian Stimulation for Women with Subfertility Undergoing Elective Fertility Preservation or Genetic Testing

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Infertility
    Investigated Drugs:
    • Corifollitropin Alfa
    • Desogestrel
    • Ganirelix
    Belgium

  • Study on Spinal Morphine, Intravenous Lidocaine, and Bupivacaine for Patients Undergoing Robot-Assisted Surgery for Kidney or Ureter Conditions

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Anhydrous Lidocaine Hydrochloride
    • Bupivacaine Hydrochloride, Anhydrous
    • Extract Of Fresh Opium Poppy (1:2.2-2.7), Extraction Solvent: Ethanol 31.2 % (M/M)
    Sweden

  • Study on Treating Acute Myeloid Leukemia in Children and Adolescents Using Gemtuzumab Ozogamicin and a Drug Combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Dexrazoxane
    • Gemtuzumab Ozogamicin
    • Etoposide Phosphate
    Belgium Denmark Estonia Finland Iceland Latvia +6

  • Study on Cobicistat, Venetoclax, and Azacitidine for Patients with Newly Diagnosed Acute Myeloid Leukemia Ineligible for Intensive Chemotherapy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Cobicistat
    • Azacitidine
    • Venetoclax
    The Netherlands
Previous Page
1 … 543 544 545 546 547 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!